By Professor Murray David Norris

Conference Papers

Vijayasubhash V; Cowley M; Haber M; Sutton R; Trahair T; Norris M; marshall G; Kamili A; Atkinson C; Ekert P; Huang L; Venn N; Fletcher J; Henderson M, 2021, 'Analysis of DNA minimal residual disease markers in pediatric solid cancers using quantitative real time PCR and droplet digital PCR', in Analysis of DNA minimal residual disease markers in pediatric solid cancers using quantitative real time PCR and droplet digital PCR, American Association for Cancer Research (AACR), PA, Philadelphia, pp. 639 - 639, presented at AACR 2021, PA, Philadelphia, 10 April 2021 - 21 May 2021, http://dx.doi.org/10.1158/1538-7445.AM2021-639

Khan A; Gamble L; Upton D; Yu D; Ehteda A; Pandher R; Mayoh C; Burns M; Norris M; Haber M; Tsoli M; Ziegler D, 2020, 'POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, pp. 289 - 290, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000606080100066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ehteda A; Franshaw L; Liu J; Joshi S; Simon S; Pang CNI; Giorgi F; Pandher R; Ung C; Tolhurst O; Mayoh C; Khan A; Hayden E; Gopalakrishnan A; Trebilcock P; Upton D; Lehmann R; George S; Vittorio O; Tsoli M; Gurova K; Gudkov AG; Norris MD; Haber M; Ziegler DS, 2020, 'TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, pp. 292 - 292, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000606080100077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haber M; Gamble L; Xiao L; Pandher R; Somers K; Murray J; Khan A; Yu D; Franshaw L; Burns MR; Tsoli M; Ehteda A; Cesare A; O’Connor A; Mussai F; de Santo C; Cheng P; Korotchkina L; Gurova K; Tyrrell V; Mould E; Lau L; Quang DAK; Mayoh C; Arndt G; Barahona P; Failes T; Fletcher J; Bolanos NF; Gauthier M-E; Gifford A; Grebert-Wade D; Kamili A; Kumar A; Nagabushan S; O’Brien T; Strong P; Sherstyuk A; Thomas D; Trahair T; Tucker K; Warby M; Wong M; Xie J; Evans K; Lock R; Chernova OB; Henderson M; Gudkov AV; Ekert P; Cowley MJ; Marshall GM; Ziegler DS; Norris MD, 2020, 'Abstract IA13: Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies', in Cancer Research, American Association for Cancer Research (AACR), pp. ia13 - ia13, http://dx.doi.org/10.1158/1538-7445.pedca19-ia13

Valli E; Xue C; Cheung L; Gamble L; Pandher R; Giacomo SD; Burkhart C; Fedtsova N; Ferrucci F; Makarov S; Telfer T; Codd R; Scott D; Perini G; Osterman A; Gudkov A; Norris M; Haber M, 2019, 'Abstract 2616: A novel iron-chelating agent reduces MYC transcription via E2F gene family regulation', in Cancer Research, American Association for Cancer Research (AACR), pp. 2616 - 2616, http://dx.doi.org/10.1158/1538-7445.am2019-2616

Valli E; Xue C; Cheung L; Gamble L; Pandher R; Giacomo SD; Burkhart C; Fedtsova N; Ferrucci F; Makarov S; Telfer T; Codd R; Scott D; Perini G; Osterman A; Gudkov A; Norris M; Haber M, 2019, 'Abstract 2616: A novel iron-chelating agent reduces MYC transcription via E2F gene family regulation', American Association for Cancer Research (AACR), pp. 2616 - 2616, presented at Molecular and Cellular Biology / Genetics, http://dx.doi.org/10.1158/1538-7445.sabcs18-2616

Nagy Z; Kanikevich M; Koach J; Mayoh C; Carter D; Liu T; Du Y; Jiang C; Haber M; Norris M; Cheung B; Marshall G, 2019, 'Abstract 3659: Alyref is a novel binding partner and co-factor for MYCN-driven oncogenesis in neuroblastoma', American Association for Cancer Research (AACR), pp. 3659 - 3659, presented at Tumor Biology, http://dx.doi.org/10.1158/1538-7445.sabcs18-3659

Hanssen KM; Gana CC; Wheatley MS; Yu DM; Flemming CL; Young R; Wright GM; Conseil G; Kennedy CJ; deFazio A; Solomon B; Cole SP; Norris MD; Haber M; Fletcher JI, 2019, 'Abstract 3809: Modulation of MRP1 activity reverses chemotherapy resistance in adult cancer cells', in Cancer Research, American Association for Cancer Research (AACR), pp. 3809 - 3809, http://dx.doi.org/10.1158/1538-7445.am2019-3809

Hanssen KM; Gana CC; Wheatley MS; Yu DM; Flemming CL; Young R; Wright GM; Conseil G; Kennedy CJ; deFazio A; Solomon B; Cole SP; Norris MD; Haber M; Fletcher JI, 2019, 'Abstract 3809: Modulation of MRP1 activity reverses chemotherapy resistance in adult cancer cells', American Association for Cancer Research (AACR), pp. 3809 - 3809, presented at Experimental and Molecular Therapeutics, http://dx.doi.org/10.1158/1538-7445.sabcs18-3809

Xiao L; Murray J; Ehteda A; Somers C; Mayoh C; Gamble L; Pandher R; Tsoli M; Eden G; Allan S; Sarraf S; Kosciolek A; Ziegler D; Henderson M; Issaeva N; Gurova K; Gudkov A; Haber M; Norris M, 2018, 'Chromatin destabilization by CBL0137 and panobinostat leads to complete tumour regression of childhood neuroblastoma in immunocompetent transgenic mice', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, IRELAND, Dublin, pp. E25 - E25, presented at 30th EORTC-NCI-AACR Symposium, IRELAND, Dublin, 13 November 2018 - 16 November 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461258600045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tee AE; Liu PY; Milazzo G; Hannan KM; Maag J; Bartonicek N; Song R; Jiang CC; Zhang XD; Norris MD; Haber M; Marshall GM; Li J; Vandesompele J; Mattick JS; Mestdagh P; Perini G; Hannan RD; Dinger ME; Liu T, 2018, 'Abstract 2453: Eradication of neuroblastoma by suppressing the expression of a single noncoding RNA', in Cancer Research, American Association for Cancer Research (AACR), pp. 2453 - 2453, http://dx.doi.org/10.1158/1538-7445.am2018-2453

Somers K; Middlemiss S; Biktasova A; Karsa M; Cheung L; Kosciolek A; Evans K; Mayoh C; Kees UR; Korotchkina L; Chernova OB; Lock RB; Gudkov AV; Haber M; Norris MD; Henderson MJ, 2017, 'Abstract 1175: Inhibition of NAMPT as a novel therapeutic strategy for infant leukemia', in Cancer Research, American Association for Cancer Research (AACR), pp. 1175 - 1175, http://dx.doi.org/10.1158/1538-7445.am2017-1175

Gao J; Somers K; Hannan KM; Fletcher JI; Liu B; Hannan RD; Pearson RB; Haber M; Norris MD; Henderson MJ, 2017, 'Abstract 1956: ABCE1 regulates the translational profile of neuroblastoma to drive tumor progression', in Cancer Research, American Association for Cancer Research (AACR), pp. 1956 - 1956, http://dx.doi.org/10.1158/1538-7445.am2017-1956

Burns MR; Fosnaugh K; Palfreyman MG; Gamble L; Murray J; Allan S; Eden G; Sarraf S; Norris M; Ziegler D; Haber M, 2017, 'Abstract 2006: AMX-513 polyamine depletion therapy inhibits tumor growth and reverses immunosuppression in cancers including MYC-driven neuroblastoma and pancreatic cancer', in Cancer Research, American Association for Cancer Research (AACR), pp. 2006 - 2006, http://dx.doi.org/10.1158/1538-7445.am2017-2006

Flynn AT; Vu A; Liu K; Scadden E; Attiyeh E; Norris M; Haber M; Hogarty M, 2017, 'Abstract 4883: Targeting tumor-amplified ODC1 with difluoromethylornithine (DFMO) inhibits global protein translation and has antitumor activity in neuroblastoma', in Cancer Research, American Association for Cancer Research (AACR), pp. 4883 - 4883, http://dx.doi.org/10.1158/1538-7445.am2017-4883

Gana CC; Hanssen K; Yu DM; Flemming C; Norris M; Haber M; Fletcher J, 2017, 'Abstract 4056: A modulator of multidrug resistance protein 1 selectively depletes glutathione and synergizes with L-buthionine sulfoximine to sensitize MRP1-expressing cancer cells to chemotherapy', in Cancer Research, American Association for Cancer Research (AACR), DC, Washington, pp. 4056 - 4056, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 01 April 2017 - 05 April 2017, http://dx.doi.org/10.1158/1538-7445.am2017-4056

Vittorio O; Brandl M; Cirillo G; Kimpton K; Hinde E; Duong HTT; Boyer C; Flemming C; Yee EMH; Kumar N; Parmar A; Pascali G; Charil A; Haber M; Norris M; Kavallaris M, 2016, 'Abstract 1340: Dextran-Catechin conjugate: An anticancer nano-modified natural compound targeting copper metabolism in neuroblastoma', in Cancer Research, American Association for Cancer Research (AACR), pp. 1340 - 1340, http://dx.doi.org/10.1158/1538-7445.am2016-1340

Xue C; Yu DM; Gherardi S; Koach J; Milazzo G; Gamble L; Liu B; Russell A; Liu T; Cheung BB; Marshall GM; Perini G; Haber M; Norris MD, 2016, 'Abstract 2450: MYCN and TFAP4 promote neuroblastoma malignancy by cooperating in the regulation a subset of target genes involved in cancer cell growth and metastasis', in Cancer Research, American Association for Cancer Research (AACR), pp. 2450 - 2450, http://dx.doi.org/10.1158/1538-7445.am2016-2450

Koach J; Murray JE; McCarroll J; Milazzo G; Perini G; Haber M; Norris MD; Fletcher JI; Cheung BB; Marshall GM, 2016, 'Targeting PA2G4, a novel MYCN co-factor, for the treatment of neuroblastoma', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, pp. S7 - S7, http://dx.doi.org/10.1016/S0959-8049(16)61016-X

Gonzales-Aloy E; Norris MD; Wang JY, 2016, 'Abstract 1917: Suppression of miR-101a contributes to leukemogenesis by regulating epigenetic and pro-survival pathways in MLL AML stem cells', in Cancer Research, American Association for Cancer Research (AACR), LA, New Orleans, pp. 1917 - 1917, presented at 107th Annual Meeting of the American-Association-of-Cancer-Research (AACR), LA, New Orleans, 16 April 2016 - 20 April 2016, http://dx.doi.org/10.1158/1538-7445.am2016-1917

Wadham C; Saletta F; Byrne JA; Trahair T; Ziegler DS; McCowage G; Marshall G; Haber M; Norris M, 2016, 'Abstract 51: Molecular profiling of relapsed childhood cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. 51 - 51, http://dx.doi.org/10.1158/1557-3265.pmsclingen15-51

Carter DR; Murray J; Cheung BB; Kalla H; Gamble L; Tsang J; Sutton S; Koach J; Syed S; Gifford A; Issaeva N; Biktasova A; Atmadibrata B; Sun Y; Sokolowski N; Ling D; Kim PY; Webber H; Clark A; Ruhle M; Liu B; Oberthuer A; Fischer M; Byrne J; Saletta F; Purmal A; Ziegler D; Liu T; Gurova KV; Gudkov AV; Norris MD; Haber M; Marshall GM, 2015, 'Abstract PR09: MYCN and is a therapeutic target in neuroblastoma', in Molecular Cancer Research, American Association for Cancer Research (AACR), pp. pr09 - pr09, http://dx.doi.org/10.1158/1557-3125.myc15-pr09

Williams R; Russell A; Bongers A; Sagnella S; Fife C; Jessup W; DeFazio A; Chenevix-Trench G; Haber M; Norris M; Henderson M, 2015, 'Abstract 313: Examining the role of ABCA1 cholesterol transporter in ovarian cancer spheroids', in Cancer Research, American Association for Cancer Research (AACR), pp. 313 - 313, http://dx.doi.org/10.1158/1538-7445.am2015-313

Kao FCL; Failes T; Arndt GM; Norris M; Kavallaris M, 2015, 'Abstract 3660: Discovery of a small molecule TUBB3/βIII-tubulin modulator in lung cancer', in Cancer Research, American Association for Cancer Research (AACR), pp. 3660 - 3660, http://dx.doi.org/10.1158/1538-7445.am2015-3660

O'Brien R; Maritz MF; Kong CF; Purgato S; Liu B; Yang C; Russell A; Murray J; Flemming C; Haber M; Perini G; Norris MD; Fletcher JI; Mackenzie KL, 2015, 'Abstract 488: High DKC1 expression supports neuroblastoma tumor cell proliferation and is strongly associated with poor patient outcomes', in Cancer Research, American Association for Cancer Research (AACR), pp. 488 - 488, http://dx.doi.org/10.1158/1538-7445.am2015-488

Koach J; Liu B; Bell JL; Hüttelmaier S; Liu T; Carter DR; Haber M; Norris MD; Fletcher J; Cheung BB; Marshall GM, 2015, 'Abstract 962: PA2G4 predicts poor prognosis in neuroblastoma patients and promotes neuroblastoma progression by enhancing MYCN protein stability', in Cancer Research, American Association for Cancer Research (AACR), pp. 962 - 962, http://dx.doi.org/10.1158/1538-7445.am2015-962

Carter DR; Murray J; Cheung BB; Kalla H; Gamble L; Tsang J; Sutton S; Koach J; Syed S; Gifford A; Issaeva N; Biktasova A; Atmadibrata B; Sun Y; Sokolowski N; Ling D; Kim PY; Webber H; Clark A; Ruhle M; Liu B; Oberthuer A; Fischer M; Byrne J; Saletta F; Purmal A; Ziegler D; Liu T; Gurova KV; Gudkov AV; Norris MD; Haber M; Marshall GM, 2015, 'MYCN and is a therapeutic target in neuroblastoma', in MOLECULAR CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, La Jolla, presented at AACR Special Conference on Myc - From Biology to Therapy, CA, La Jolla, 07 January 2015 - 10 January 2015, http://dx.doi.org/10.1158/1557-3125,MYC15-PRO9

Hedditch EL; Henderson MJ; Russell AJ; Gao B; Emmanuel C; Williams RT; Flemming C; Johnatty S; George J; MacGregor S; Bowtell D; Chenevix-Trench G; Defazio A; Norris MD; Haber M, 2015, 'ASSOCIATION OF ABCA1 CHOLESTEROL TRANSPORTER WITH POOR OUTCOME AND AGGRESSIVE PHENOTYPE IN SEROUS OVARIAN CANCER', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 114 - 114

Dietrich PA; Norris MD; Wang JY, 2014, 'GNA13, a Novel Component of the GPR84/Beta-Catenin Signaling Axis in AML Stem Cells, Regulates the Maintenance of MLLAF9 Leukemogenesis', in Blood, American Society of Hematology, pp. 3577, http://dx.doi.org/10.1182/blood.v124.21.3577.3577

Heong V; Topp M; Khambatta V; Rutkowski R; Ananda S; Wong S; McNally O; Swisher E; Lindeman G; Haber M; Norris M; Haluska P; Wakefield M; Bowtell D; Scott CL, 2014, 'NOVEL STRATEGIES TO TARGET THE C5 SUBCLASS OF HIGH-GRADE SEROUS OVARIAN CANCER (HGSC) USING PATIENT-DERIVED XENOGRAFTS.', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 1018 - 1019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966501301&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haber M; Murray J; Gamble L; Carnegie-Clark A; Webber H; Ruhle M; Carter D; Oberthur A; Fischer M; Ziegler D; Marshall GM; Gurova K; Burkhart C; Purmal A; Gudkov AV; Norris MD, 2014, '422 CBL0137, a novel NFkB suppressor and p53 activator, is highly effective in pre-clinical models of neuroblastoma', in European Journal of Cancer, Elsevier, pp. 135, http://dx.doi.org/10.1016/s0959-8049(14)70548-9

Haber M; Murray J; Carnegie-Clark A; Webber H; Marshall GM; Gurova KV; Burkhart CA; Purmal A; Gudkov AV; Norris MD, 2013, 'Abstract 2759: Anticancer compound curaxin CBL0137, that simultaneously suppresses NF-κB and activates p53, is highly effective in two independent mouse models of neuroblastoma.', in Cancer Research, American Association for Cancer Research (AACR), pp. 2759 - 2759, http://dx.doi.org/10.1158/1538-7445.am2013-2759

Norris MD; Gamble LD; Murray J; Purgato S; Milazzo G; Ashton LJ; Oberthuer A; London WB; Hogarty MD; Fischer M; Ziegler D; Marshall GM; Perini G; Haber M, 2013, 'Abstract 3808: MYCN coordinately regulates the entire polyamine gene pathway to drive polyamine biosynthesis in neuroblastoma, with expression of every synthetic and catabolic polyamine pathway gene being highly prognostic of clinical outcome.', in Cancer Research, American Association for Cancer Research (AACR), pp. 3808 - 3808, http://dx.doi.org/10.1158/1538-7445.am2013-3808

Carter DR; Cheung BB; Liu T; Au C; Norris MD; Haber M; Murray J; Gurova KV; Gudkov AV; Marshall GM, 2013, 'Abstract 5043: The facilitates chromatin transcription (FACT) protein complex promotes neuroblastoma tumor initiation.', in Cancer Research, American Association for Cancer Research (AACR), pp. 5043 - 5043, http://dx.doi.org/10.1158/1538-7445.am2013-5043

Huynh T; Tivnan A; Munoz M; Cheung L; Vishvanath A; Flemming C; Watt F; Burkhart C; Gudkov A; Fletcher J; Henderson M; Norris M; Haber M, 2012, 'Abstract 1834: Targeting ABC transporters in cancer through small molecule inhibitors', in Cancer Research, American Association for Cancer Research (AACR), pp. 1834 - 1834, http://dx.doi.org/10.1158/1538-7445.am2012-1834

Norris MD; Fletcher JI; Gherardi S; Murray J; Burkhart C; Russell A; Valli E; Oberthuer A; Ashton LJ; London WB; Marshall GM; Perini G; Haber M, 2012, 'Abstract 789: GSTP1 expression is regulated by MycN and is a marker of poor outcome in childhood neuroblastoma', in Cancer Research, American Association for Cancer Research (AACR), pp. 789 - 789, http://dx.doi.org/10.1158/1538-7445.am2012-789

Henderson MJ; Hedditch EL; Russell AJ; deFazio A; Emmanuel C; George J; Chenevix-Trench G; Bowtell D; Norris MD; Haber M, 2011, 'Abstract 1660: Cholesterol efflux transporter gene expression predicts clinical outcome in serous ovarian cancer', in Cancer Research, American Association for Cancer Research (AACR), pp. 1660 - 1660, http://dx.doi.org/10.1158/1538-7445.am2011-1660

Xue C; Cheung L; Norris MD; Haber M; Burkhart C; Fedtsova N; Gudkov A; Makarov SS, 2011, 'Abstract 617: Small molecule that simultaneously inhibits Myc oncoprotein and activates HIF1A', in Cancer Research, American Association for Cancer Research (AACR), pp. 617 - 617, http://dx.doi.org/10.1158/1538-7445.am2011-617

Norris MD; Henderson MJ; Porro A; Munoz M; Iraci N; Xue C; Murray J; Flemming C; Fletcher J; Gherardi S; Kwek A; Russell A; London WB; Buxton AB; Ashton L; Sartorelli AC; Cohn SL; Schwab M; Marshall GM; Perini G; Haber M, 2011, 'Abstract 954: ABCC/MRP multidrug transporters contribute to neuroblastoma biology, pathogenesis and clinical outcome, independently of any role in cytotoxic drug efflux', in Cancer Research, American Association for Cancer Research (AACR), pp. 954 - 954, http://dx.doi.org/10.1158/1538-7445.am2011-954

Lau DT; Norris MD; Marshall GM; Haber M; Ashton LJ, 2011, 'Abstract LB-367: New evidence supports the potential use of methotrexate in children with MYCN -amplified neuroblastoma.', in Cancer Research, American Association for Cancer Research (AACR), pp. lb-367-lb-367, http://dx.doi.org/10.1158/1538-7445.am2011-lb-367

Marshall GM; Gherardi S; Xu N; Neiron Z; Trahair T; Scarlett C; Chang DK; Liu PY; Jankowski K; Iraci N; Haber M; Norris MD; Stossi F; Katzenellenbogen BS; Biankin AV; Perini G; Liu T, 2010, 'Abstract 4869: Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects', in Cancer Research, American Association for Cancer Research (AACR), pp. 4869 - 4869, http://dx.doi.org/10.1158/1538-7445.am10-4869

Lau DT; Murray J; Norris M; Marshall GM; Haber M; Ashton LJ, 2010, 'Abstract 888: Reduced folate carrier gene polymorphism (RFC 80G>A): Associations with clinical outcome in NMYC amplified neuroblastoma patients', in Cancer Research, American Association for Cancer Research (AACR), pp. 888 - 888, http://dx.doi.org/10.1158/1538-7445.am10-888

Haber M; Porro A; Diolaiti D; Iraci N; Henderson M; Munoz M; Xue C; Flemming C; Murray J; London W; Buxton A; Ashton L; Cohn S; Schwab M; Marshall G; Della Valle G; Perini G; Norris M, 2009, 'A specific transcription signature of ABC transporter genes is dictated by Myc-family oncogenes: A powerful tool to predict clinical outcome', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209701803375&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Evageliou N; Vu A; Liu X; Manning R; Hayes C; Norris M; Marshall G; Haber M; Gilmour S; Hogarty M, 2009, 'Dual Targeting of AMD1 and ODC1 potently inhibits neuroblastoma initiation in vitro and in vivo', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702803498&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sekyere E; Thomas W; Chui H; Keating J; Chen JB; Davis N; Cheung B; Raif A; Jankowski K; Cheng A; Kees U; Ellis T; Wainwright B; Norris M; Haber M; Trahair T; Shohet J; Ding H-F; Marshall G, 2009, 'Perinatal Myc signalling as a mechanism of embryonal cancer initiation', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702603052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu T; Neiron Z; Norris M; Haber M; Marshall G, 2009, 'The role of N-Myc-induced HDAC2 over-expression in neuroblastoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209701802056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas W; Chen J; Gao Y; Koach J; Cheung B; Ellis T; Norris M; Haber M; Wainwright B; Marshall G, 2008, 'STABILIZATION OF THE MYCN ONCOPROTEIN AS A MECHANISM OF INITIATION AND PROGRESSION IN MEDULLOBLASTOMA RESULTING FROM SONIC HEDGEHOG PATHWAY ACTIVATION', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, NV, Las Vegas, pp. 870 - 870, presented at 13th Annual Meeting of the Society-for-Neuro-Oncology (SNO), NV, Las Vegas, 20 November 2008 - 23 November 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259854500409&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Williams B; Bertoncello I; Kershaw M; Haber M; Norris M; Darcy P; Ramsay R, 2008, 'Effective anti-colon cancer immunity induced through the targeting of the nuclear oncogene c-Myb by DNA vaccination in a mouse model', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SPAIN, Barcelona, pp. 77 - 77, presented at 10th World Congress on Gastrointestinal Cancer, SPAIN, Barcelona, 25 June 2008 - 28 June 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257951800259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haber M; Cheng N; Smith J; Murray J; Hogarty MD; London WB; Marshall GM; Norris MD, 2008, 'Abstract 5832: Overexpression of ODC1 is associated with poor outcome in childhood neuroblastoma and represents an important therapeutic target', in Cancer Research, American Association for Cancer Research (AACR), pp. 5832 - 5832, http://dx.doi.org/10.1158/1538-7445.am2008-5832

Tee ELA; Liu T; Haber M; Norris MD; Marshall GM, 2008, 'Full-length tissue transglutaminase is a resistance factor for cell differentiation in neuroblastoma', in European Journal of Cancer Supplements, Elsevier, pp. 94, http://dx.doi.org/10.1016/s1359-6349(08)71539-8

Back to profile page